Stocks / NASDAQ / Legend Biotech Corporation

Legend Biotech Corporation

Our Opinion

Legend Biotech Corporation is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Long-term anti-tumor activity and extended animal survival were observed in animals treated with LGkine-armored CAR-NK cells.” (Page 88) Read the full document

Company Description

Legend Biotech Corporation. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, LCAR- B38M (cilta-cel), is an autologous CAR-T cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in a number of hematologic malignancies, including multiple myeloma (MM).

Company Website: